Extracorporeal Immunoglobulin Elimination for the Treatment of Severe Myasthenia Gravis

Myasthenia gravis (MG) is a neuromuscular disorder leading to fluctuating muscle weakness and fatigue. Rarely, long-term stabilization is not possible through the use of thymectomy or any known drug therapy. We present our experience with extracorporeal immunoglobulin (Ig) elimination by immunoadsor...

Descripción completa

Detalles Bibliográficos
Autores principales: Blaha, M., Pit'ha, J., Blaha, V., Lanska, M., Maly, J., Filip, S., Langrova, H.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2840412/
https://www.ncbi.nlm.nih.gov/pubmed/20300435
http://dx.doi.org/10.1155/2010/419520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2840412/
https://www.ncbi.nlm.nih.gov/pubmed/20300435
http://dx.doi.org/10.1155/2010/419520

Ejemplares similares